Over One-Third of Under 50s Are Open to Psychedelic Trials for Mental Health Treatment
Aside from psilocybin, those aged between 18-24 were most interested psychedelic trials with ketamine (27%) and MDMA (26%).
psychedelic clinical trials
UK Psychedelic Trials Start-Up Issues National Call for Volunteers to Trial Innovative Medicines for Mental Health Disorders
Clerkenwell Health is today issuing a national call for volunteers to step forward for upcoming trials testing psychedelic drugs.
The FDA Issues Guidance on Designing Psychedelic Clinical Trials
The Food and Drug Administration published a new draft guidance with the purpose to advise researchers on study design when investigating the potential of psychedelics.
Will the UK’s Ambitious Life Sciences Investment Power-Up the Psychedelic Sector?
As an emerging innovative sector addressing unmet mental health needs, psychedelic drug developers are poised to greatly benefit from the diverse initiatives offered within this package.
Want to Try Psychedelics in a Clinical Setting? 116 Trials Now Recruiting Volunteers (UPDATED)
Here’s how to become a research subject for psilocybin, LSD, MDMA, ibogaine, DMT and 5-MeO-DMT studies.
Brain Scanning Technology to be Used for Psychedelic Clinical Trials in Pioneering London Start-Up Partnership
A start-up partnership between Clerkenwell Health and MYndspan will use brain scanning technology for psychedelic clinical trials.
Psychedelic Business Spotlight – June 3
This week in psychedelic business news: Cybin moves towards clinical trials; Braxia releases data on treating depression with psilocybin; Clearmind files for a new patent; and much more!
How to Enroll in a Psychedelic Clinical Trial in 5 Easy Steps
Interested in participating in a psychedelic study? Here’s an in-depth walk through guide so you can take actionable steps to make it happen.
End of content
End of content